Cervical leiomyosarcoma is known to be rare from the previous reviews of a large number of malignant cervical tumors. The patient was a 66-year-old woman with irregular vaginal bleeding. She underwent modified radical hysterectomy and bilateral salpingooophorectomy. Histopathologically, we diagnosed the coexistence of uterine cervical leiomyosarcoma and cervical gastric-type adenocarcinoma in situ with endometrial lesions that had continuous and skip patterns and fallopian tubal lesions with a partial lesion. To the best of our knowledge, cases of synchronous leiomyosarcoma and cancers have not often been reported; only two cases of synchronous cervical leiomyosarcoma and cervical squamous cell carcinoma have been published. This case is the first presentation of coincidental primary cervical leiomyosarcoma and cervical gastric-type adenocarcinoma in situ. Additionally, we considered cervical gastric-type adenocarcinoma in situ with continuous lesions on the endometrium and skip lesions on the left fallopian tube.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835282PMC
http://dx.doi.org/10.1155/2018/5848629DOI Listing

Publication Analysis

Top Keywords

cervical leiomyosarcoma
20
gastric-type adenocarcinoma
16
adenocarcinoma situ
16
leiomyosarcoma cervical
12
cervical gastric-type
12
cervical
9
fallopian tube
8
cases synchronous
8
leiomyosarcoma
6
coexistence cervical
4

Similar Publications

Article Synopsis
  • HER2 overexpression is a significant target for treating gynecological cancers, and Trastuzumab-Deruxtecan (T-DXd) has shown notable effectiveness against these cancers, particularly in ovarian, endometrial, and cervical malignancies.
  • A study was conducted at the Alexandra Hospital in Athens involving 10 patients with HER2-positive gynecological cancers who were treated with T-DXd, administered intravenously every 3 weeks.
  • Results indicated a median progression-free survival of 5.4 months, with 5 patients achieving a partial response, highlighting T-DXd's potential as a treatment option even for patients with prior therapies.
View Article and Find Full Text PDF

Artificial Intelligence in Obstetric and Gynecological MR Imaging.

Magn Reson Med Sci

October 2024

Department of Diagnostic and Interventional Radiology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Article Synopsis
  • The review highlights advancements in the use of artificial intelligence (AI) in obstetrics and gynecological MRI, detailing its evolution from basic algorithms to deep learning techniques.
  • It discusses recent research utilizing AI to identify various medical conditions like uterine leiomyosarcoma and endometrial cancer, as well as improvements in MRI segmentation and quality.
  • The text notes ongoing challenges in the field while emphasizing the potential of AI to enhance diagnostic accuracy and support personalized medicine through better access to large datasets and multiparametric MRI technology.
View Article and Find Full Text PDF

This study aims to analyze the clinicopathological characteristics and survival outcomes of cutaneous soft tissue sarcomas (CSTS) in children. We selected pediatric cases of CSTS diagnosed between 2000 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database. Survival rates were calculated using Kaplan-Meier methods.

View Article and Find Full Text PDF

Uterine leiomyomas are a frequent finding in women of reproductive age. However, rare, unusual growth patterns exist, such as atypical, cellular, mitotically active, myxoid, and epithelioid leiomyomas, and present a major concern as they mimic highly malignant uterine tumors such as uterine leiomyosarcomas. An example of such cases is the epithelial type leiomyoma which is the subject of our report in a 35-year-old female.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!